LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 2 of 535
Next
>>
>
26 to 50 of 13356 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	AZD7762	0.04	uM	LJP6	2	L06	72	hr	1657	6318	5360	1.1787	1.2039
BT-20	AZD7762	0.12	uM	LJP6	2	L05	72	hr	1657	5285	5360	0.9860	0.9834
BT-20	AZD7762	0.12	uM	LJP6	3	L05	72	hr	1657	5188	5546	0.9354	0.9248
BT-20	AZD7762	0.37	uM	LJP6	2	L04	72	hr	1657	4107	5360	0.7662	0.7089
BT-20	AZD7762	0.37	uM	LJP6	3	L04	72	hr	1657	4137	5546	0.7459	0.6903
BT-20	Seliciclib	0.04	uM	LJP5	1	J06	72	hr	1657	5649	5624	1.0044	1.0050
BT-20	Seliciclib	0.04	uM	LJP5	2	J06	72	hr	1657	5742	5610	1.0234	1.0265
BT-20	Seliciclib	0.12	uM	LJP5	1	J05	72	hr	1657	5349	5624	0.9511	0.9439
BT-20	Seliciclib	0.12	uM	LJP5	2	J05	72	hr	1657	5765	5610	1.0275	1.0311
BT-20	Seliciclib	0.37	uM	LJP5	2	J04	72	hr	1657	5240	5610	0.9339	0.9238
BT-20	Seliciclib	0.37	uM	LJP5	3	J04	72	hr	1657	5100	5529	0.9223	0.9091
BT-20	Seliciclib	1.11	uM	LJP5	2	J03	72	hr	1657	4956	5610	0.8833	0.8638
BT-20	Seliciclib	1.11	uM	LJP5	3	J03	72	hr	1657	4738	5529	0.8569	0.8299
BT-20	Seliciclib	10	uM	LJP5	1	J01	72	hr	1657	2369	5624	0.4212	0.2245
BT-20	Seliciclib	10	uM	LJP5	2	J01	72	hr	1657	2227	5610	0.3969	0.1827
BT-20	AT-7519	0.04	uM	LJP6	1	K06	72	hr	1657	5160	5244	0.9838	0.9805
BT-20	AT-7519	0.04	uM	LJP6	2	K06	72	hr	1657	5258	5360	0.9809	0.9774
BT-20	AT-7519	0.12	uM	LJP6	2	K05	72	hr	1657	4398	5360	0.8205	0.7794
BT-20	AT-7519	0.12	uM	LJP6	3	K05	72	hr	1657	4202	5546	0.7577	0.7055
BT-20	AT-7519	0.37	uM	LJP6	2	K04	72	hr	1657	1973	5360	0.3681	0.1083
BT-20	AT-7519	0.37	uM	LJP6	3	K04	72	hr	1657	1881	5546	0.3392	0.0752
BT-20	AT-7519	3.33	uM	LJP6	2	K02	72	hr	1657	1094	5360	0.2041	-0.2177
BT-20	AT-7519	3.33	uM	LJP6	3	K02	72	hr	1657	1297	5546	0.2339	-0.1314
BT-20	AZD7762	3.33	uM	LJP6	2	L02	72	hr	1657	1615	5360	0.3013	-0.0153
BT-20	AZD7762	3.33	uM	LJP6	1	L02	72	hr	1657	1660	5244	0.3165	0.0008

|<
<<
Previous
Page 2 of 535
Next
>>
>
26 to 50 of 13356 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)